C07F 9/306
Arylalkanephosphinic acids
Official title: {Arylalkanephosphinic acids, e.g. Ar-(CH2)n-P(=X)(R)(XH), (X = O,S, Se; n>=1)}
C07F9/306 (Arylalkanephosphinic acids) appears on 44 US grants and 38 published applications in this corpus.
Search patents in C07F- Granted patents
- 44
- Published applications
- 38
- Assignees
- 33
- Inventors
- 117
- Latest grant
- 10 May 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 2 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 2 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 5 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 2 |
| 2006 | 0 | 3 |
| 2007 | 1 | 1 |
| 2008 | 1 | 1 |
| 2009 | 3 | 4 |
| 2010 | 1 | 4 |
| 2011 | 1 | 6 |
| 2012 | 2 | 2 |
| 2013 | 2 | 2 |
| 2014 | 1 | 2 |
| 2015 | 2 | 1 |
| 2016 | 1 | 3 |
| 2017 | 0 | 0 |
| 2018 | 3 | 2 |
| 2019 | 2 | 0 |
| 2020 | 0 | 1 |
| 2021 | 1 | 1 |
| 2022 | 1 | 1 |
| 2023 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Phosphorus-containing compound and preparation and use thereof10 May 2022US 11,325,929 B2VivaVisionShanghaiLtd
- Aminopeptidase A inhibitors and pharmaceutical compositions comprising the same7 Dec 2021US 11,192,907 B2Centre National De La Recherche Scientifique
- β-substituted β-amino acids and analogs as chemotherapeutic agents2 Apr 2019US 10,245,246 B2Quadriga Biosciences, Inc.
- Phosphinic peptide derivatives for use as MMP-12 inhibitors15 Jan 2019US 10,179,797 B2Dsm IP Assets B.V.
- Aminophosphinic derivatives that can be used in the treatment of pain20 Nov 2018US 10,131,681 B2Pharmaleads
- Gpr40 agonists18 May 2023US 2023/0151037 A1Kallyope, Inc.
- Gpr40 agonists21 Jul 2022US 2022/0226298 A1Kallyope, Inc.
- Aminopeptidase a inhibitors and pharmaceutical compositions comprising the same7 Oct 2021US 2021/0309678 A1Centre National De La Recherche Scientifique
- Phosphorus-containing compound and preparation and use thereof30 Apr 2020US 2020/0131206 A1VivaVisionShanghaiLtd
- Phosphinic peptide derivatives for use as mmp-12 inhibitors8 Nov 2018US 2018/0319829 A1Dsm IP Assets B.V.
Most cited
By later US patents
- Phosphinylalkanoyl prolines104US 4,168,267 AE. R. Squibb & Sons, Inc. · 1979
- Amino and substituted amino phosphinyl-alkanoyl compounds66US 4,374,131 AE. R. Squibb & Sons, Inc. · 1983
- Phosphorus containing compounds and use as hypotensives56US 4,555,506 AE. R. Squibb & Sons, Inc. · 1985
- Aminoalkyl and related substituted phosphinic acid angiotensin converting enzyme inhibitors36US 4,452,791 AE. R. Squibb & Sons, Inc. · 1984
- Gamma-amino-butyric acid derivatives as GABAB receptor ligands34US 8,344,028 B2XenoPort, Inc. · 2013